Clincosm LogoSign in Get a demo

Advanced Biliary Tract Cancer

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 11, 2023

Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Apr 7, 2023

Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 2, 2023

Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

Recruiting
  • Advanced Biliary Tract Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 22, 2023

Advanced Biliary Tract Cancer Trial in Changsha (IBI310, sintilimab)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Changsha, Hunan, China
    Hunan cancer Hospital
Dec 13, 2022

Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

Recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Albury, New South Wales, Australia
  • +11 more
Oct 31, 2022

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022

Advanced Biliary Tract Cancer Trial in Taipei (Lenvatinib Pill,Paclitaxel)

Recruiting
  • Advanced Biliary Tract Cancer
  • Lenvatinib Pill,Paclitaxel
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Jul 27, 2022

Advanced Biliary Tract Cancer Trial in United States (Durvalumab, Regorafenib)

Recruiting
  • Advanced Biliary Tract Cancer
  • Overland Park, Kansas
  • +4 more
May 17, 2022

Advanced Biliary Tract Cancer Trial in Beijing (OXA, 5-FU and bevacizumab plus Toripalimab)

Recruiting
  • Advanced Biliary Tract Cancer
  • OXA, 5-FU and bevacizumab plus Toripalimab
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Nov 26, 2021

Advanced Biliary Tract Cancer Trial in Taiwan (TS-1, Gemcitabine, Nivolumab)

Active, not recruiting
  • Advanced Biliary Tract Cancer
  • Kaohsiung, Taiwan
  • +5 more
Dec 7, 2021

Advanced Biliary Tract Cancer Trial in Washington, Indianapolis, Saint Louis (Nanoliposomal Irinotecan, Leucovorin,

Recruiting
  • Advanced Biliary Tract Cancer
  • Nanoliposomal Irinotecan
  • +2 more
  • Washington, District of Columbia
  • +2 more
Oct 29, 2021

Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Irinotecan Liposome Injection
  • +3 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021

Advanced Non-small-cell Lung Cancer, Advanced Biliary Tract Cancer Trial (SC-43, Cisplatin)

Not yet recruiting
  • Advanced Non-small-cell Lung Cancer
  • Advanced Biliary Tract Cancer
  • (no location specified)
Jan 28, 2021

Advanced Biliary Tract Cancer Trial in Seoul (Sitravatinib, Tislelizumab)

Unknown status
  • Advanced Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 23, 2021

Advanced Biliary Tract Cancer Trial in Aurora (SPARC1507, Reference1507)

Withdrawn
  • Advanced Biliary Tract Cancer
  • Aurora, Colorado
    SPARC study site
Dec 10, 2020

Advanced Biliary Tract Cancer Trial in Beijing (Toripalimab plus Lenvatinib)

Unknown status
  • Advanced Biliary Tract Cancer
  • Toripalimab plus Lenvatinib
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Nov 30, 2020

Advanced Biliary Tract Cancer Trial in Beijing (Toripalimab Combined With S1 and Albumin Paclitaxel)

Unknown status
  • Advanced Biliary Tract Cancer
  • Toripalimab Combined With S1 and Albumin Paclitaxel
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jul 18, 2019

Advanced Biliary Tract Cancer Trial in Seoul (Natural killer cell)

Completed
  • Advanced Biliary Tract Cancer
  • Natural killer cell
  • Seoul, Korea, Republic of
    Division of Gastroenterology, Department of Internal Medicine, Y
Jan 15, 2019